Displaying 1 to 1 of 1 investments
Country Date Notes
Incuron
Developer of the innovative class of drug substance (curaxins) for oncological and autoimmune treatment diseases 		Russia 12 Jan 2010 N/A
USD 18,000,000 (USD 18,000,000) deal size. Active